Asymmetric Dimethylarginine, Endothelial Dysfunction and Renal Disease

Intravenous N-acetylcysteine during hemodialysis reduces asymmetric dimethylarginine level in end-stage renal disease patients

(2013) M. Thaha et al.   CLINICAL NEPHROLOGY

Asymmetric Dimethylarginine: A Novel Cardiovascular Risk Factor in End-Stage Renal Disease

(2013) M Yusuf Alsagaff et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Asymmetric dimethylarginine in adults with cystathionine β-synthase deficiency

(2012) Monica S. Rocha et al.   ATHEROSCLEROSIS

Free asymmetric dimethylarginine (ADMA) is low in children and adolescents with classical phenylketonuria (PKU)

(2012) M. Huemer et al.   JOURNAL OF INHERITED METABOLIC DISEASE

ADMA and NOS regulation in chronic renal disease: beyond the old rivalry for l-arginine

(2012) Anca D. Dobrian   KIDNEY INTERNATIONAL

Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine

(2012) Hidemi Kajimoto et al.   KIDNEY INTERNATIONAL

Proteinuria elevates asymmetric dimethylarginine levels via protein arginine methyltransferase-1 overexpression in a rat model of nephrotic syndrome

(2012) Yusuke Kaida et al.   LIFE SCIENCES

High tea and vegetable consumption is associated with low ADMA generation in older healthy subjects

(2012) Tadeusz Goralczyk et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

A Functional Variant of the Dimethylarginine Dimethylaminohydrolase-2 Gene Is Associated with Insulin Sensitivity

(2012) Francesco Andreozzi et al.   PLoS One

Arginine and Asymmetric Dimethylarginine in Puromycin Aminonucleoside-Induced Chronic Kidney Disease in the Rat

(2011) Gin-Fu Chen et al.   AMERICAN JOURNAL OF NEPHROLOGY

A simple and fast liquid chromatography–tandem mass spectrometry method for measurement of underivatized l-arginine, symmetric dimethylarginine, and asymmetric dimethylarginine and establishment of the reference ranges

(2011) Joe M. El-Khoury et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Inflammation and Asymmetric Dimethylarginine for Predicting Death and Cardiovascular Events in ESRD Patients

(2011) G. Tripepi et al.   Clinical Journal of the American Society of Nephrology

Asymmetric Dimethylarginine and Clinical Outcomes in Chronic Kidney Disease

(2011) T.-M. Lu et al.   Clinical Journal of the American Society of Nephrology

Symmetric Dimethylarginine as a Proinflammatory Agent in Chronic Kidney Disease

(2011) E. Schepers et al.   Clinical Journal of the American Society of Nephrology

Muscle and Fat Metabolism in Obesity After Kidney Transplantation: No Effect of Peritoneal Dialysis or Hemodialysis

(2011) Vladimír Teplan et al.   JOURNAL OF RENAL NUTRITION

Asymmetric Dimethylarginine: Clinical Applications in Pediatric Medicine

(2011) You-Lin Tain et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Guanidino Compounds as Cause of Cardiovascular Damage in Chronic Kidney Disease: An in vitro Evaluation

(2010) Eva Schepers et al.   BLOOD PURIFICATION

Endothelial Dysfunction and Subsequent Decline in Glomerular Filtration Rate in Hypertensive Patients

(2010) Francesco Perticone et al.   CIRCULATION

Circulating levels of asymmetric dimethylarginine are an independent risk factor for left ventricular hypertrophy and predict cardiovascular events in pre-dialysis patients with chronic kidney disease

(2010) Beili Shi et al.   European Journal of Internal Medicine

Methylation cycle, arginine-creatine pathway and asymmetric dimethylarginine in paediatric renal transplant

(2010) F. Andrade et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The differences of asymmetric dimethylarginine removal by different dialysis treatments

(2010) Dong-Liang Zhang et al.   RENAL FAILURE

Adenoviral-mediated overexpression of DDAH improves vascular tone regulation

(2010) Belen Torondel et al.   VASCULAR MEDICINE

Molecular Mechanisms of Endothelial Dysfunction: From Nitric Oxide Synthesis to ADMA Inhibition

(2009) Valmore Bermúdez et al.   AMERICAN JOURNAL OF THERAPEUTICS

Dimethylarginines and inflammation markers in patients with chronic kidney disease undergoing dialysis

(2009) Yildiz Oner-Iyidogan et al.   CLINICAL AND EXPERIMENTAL MEDICINE

Distribution of Asymmetric Dimethylarginine among 980 Healthy, Older Adults of Different Ethnicities

(2009) K. Sydow et al.   CLINICAL CHEMISTRY

Asymmetric Dimethylarginine and Mortality in Stages 3 to 4 Chronic Kidney Disease

(2009) J. M. Young et al.   Clinical Journal of the American Society of Nephrology

Endothelial dysfunction, ADMA and insulin resistance in essential hypertension

(2009) Francesco Perticone et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Clinical Implications of Elevated Asymmetric Dimethylarginine in Chronic Kidney Disease and End-Stage Renal Disease

(2009) Francesca Mallamaci et al.   JOURNAL OF RENAL NUTRITION

Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients

(2009) Sadollah Abedini et al.   KIDNEY INTERNATIONAL

Evaluation of Asymmetric Dimethylarginine and Homocysteine in Microangiopathy-Related Cerebral Damage

(2008) Y. Notsu et al.   AMERICAN JOURNAL OF HYPERTENSION

Randomized Placebo-Controlled Trial Assessing a Treatment Strategy Consisting of Pravastatin, Vitamin E, and Homocysteine Lowering on Plasma Asymmetric Dimethylarginine Concentration in Mild to Moderate CKD

(2008) Prabath W.B. Nanayakkara et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia

(2008) Sanjana Dayal et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population

(2008) Stefan Kiechl et al.   ATHEROSCLEROSIS

Asymmetric dimethylarginine: a novel marker of risk and a potential target for therapy in chronic kidney disease

(2008) Jan T Kielstein et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine

(2008) Mei Feng et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Arginine and methylated arginines in human plasma and urine measured by tandem mass spectrometry without the need for chromatography or sample derivatisation

(2008) G WEAVING et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Oxidative Stress and Asymmetric Dimethylarginine Are Associated with Cardiovascular Complications in Hemodialysis Patients: Improvements by L-Arginine Intake

(2008) Hala O. El-Mesallamy et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients

(2008) KRISTEN M. BEAVERS et al.   NEPHROLOGY

Assessment of the cardiovascular system in pediatric chronic kidney disease: a pilot study

(2008) Jutta Muscheites et al.   PEDIATRIC NEPHROLOGY

Methylated arginine derivatives in children and adolescents with chronic kidney disease

(2008) Ellen R. Brooks et al.   PEDIATRIC NEPHROLOGY

Elevated plasma adiponectin and decreased plasma homocysteine and asymmetric dimethylarginine in children with type 1 diabetes

(2008) Kaire Heilman et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Reduction of plasma asymmetric dimethylarginine in obese patients with chronic kidney disease after three years of a low-protein diet supplemented with keto-amino acids: a randomized controlled trial

(2008) Vladimir Teplan et al.   WIENER KLINISCHE WOCHENSCHRIFT

Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism

(2007) Edzard Schwedhelm et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Asymmetric Dimethylarginine and Adiponectin After Renal Transplantation: Role of Obesity

(2007) Vladimir Teplan et al.   JOURNAL OF RENAL NUTRITION